Observational studyMedicina (Kaunas, Lithuania)2026

CYP3A4, CYP3A5, and CYP4F2 Polymorphisms and Bleeding Risk in Ticagrelor-Based Dual Antiplatelet Therapy.

Sonja Dakić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.